Vinge has advised Sigrid Therapeuctis AB in connection with a combined directed issue and rights offering.
Sigrid Therapeutics is pioneering a user-friendly product made of precisely engineered particles with extraordinary absorptive capacity. The product works mechanically in the gut to improve glycemic control in a safe and effective way.
Vinge’s team primarily consisted of Kristoffer Franzkeit and Astrid Karlsson.
